Skip to main content

Table 1 Demographic data at time of inclusion

From: Endomyocardial, intralymphocyte, and whole blood concentrations of ciclosporin A in heart transplant recipients

 

All

No-rejection group

Rejection group

P value

Gender (male/female)

8/2

2/5

3/0

-

Weight (kg)

76.7 ± 18.0

73.9 ± 19.5

83.3 ± 15.0

0.517

Age (years)

51.9 ± 11.9

51.0 ± 12.9

54.0 ± 11.5

0.833

CsA dose (mg/day)

330 ± 115

293 ± 116

417 ± 57.7

0.183

CsA C0 (ng/mL)

245 ± 59.3

239 ± 71.7

257 ± 10.4

0.383

Plasma creatinine (μmol/L)

131 ± 55

146 ± 59.8

96.5 ± 16.5

0.117

Creatinine clearance (mL/min)

58.0 ± 21.4

50.3 ± 18.9

77.6 ± 14.7

0.067

Serum urea (mmol/L)

10.5 ± 5.3

10.8 ± 6.0

9.8 ± 3.8

1.000

Hematocrit (%)

32.3 ± 4.2

32.3 ± 4.9

32.5 ± 0.7

0.500

Steroid dose (mg/day)

14.8 ± 3.8

13.6 ± 3.7

17.5 ± 2.5

0.137

Treated with MMF

10/10

7/7

3/3

-

  1. Data are means ± SD. All variables were analyzed with a Mann–Whitney U test.
  2. CsA, cyclosporine A; MMF, mycophenolate mofetil.